Home
>
National Drug Code (NDC)
>
Dactinomycin
Dactinomycin - 55390-337-01 - (Dactinomycin)
Drug Information of Dactinomycin
| Product NDC: | 55390-337 |
| Proprietary Name: | Dactinomycin |
| Non Proprietary Name: | Dactinomycin |
| Active Ingredient(s): | 500 ug/1 & nbsp; Dactinomycin |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, POWDER, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Dactinomycin
| Product NDC: | 55390-337 |
| Labeler Name: | Bedford Laboratories |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA090304 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20100712 |
Package Information of Dactinomycin
| Package NDC: | 55390-337-01 |
| Package Description: | 1 VIAL in 1 BOX (55390-337-01) > 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
NDC Information of Dactinomycin
| NDC Code | 55390-337-01 |
| Proprietary Name | Dactinomycin |
| Package Description | 1 VIAL in 1 BOX (55390-337-01) > 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| Product NDC | 55390-337 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Dactinomycin |
| Dosage Form Name | INJECTION, POWDER, FOR SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20100712 |
| Marketing Category Name | ANDA |
| Labeler Name | Bedford Laboratories |
| Substance Name | DACTINOMYCIN |
| Strength Number | 500 |
| Strength Unit | ug/1 |
| Pharmaceutical Classes | Actinomycin [EPC],Nucleic Acid Synthesis Inhibitors [MoA],Protein Synthesis Inhibitors [MoA] |
